RASSF8 is a negative regulator of NF-κB transcriptional activity in lung cancer [17], where the regulatory protein IκB-α is degraded and p65 dimers enter the nucleus following RASSF8 knockdown in A549 and H1792 cell lines. This evidence concerns the gene RASSF8 and lung carcinoma.